US Patent Issued to KING FAISAL UNIVERSITY on April 29 for "Substituted pyrimido[4,5-bindoles as CK2 inhibitors" (Saudi Arabia Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,436, issued on April 29, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).

"Substituted pyrimido[4,5-bindoles as CK2 inhibitors" was invented by Michelyne Haroun (Al-Ahsa, Saudi Arabia) and Christophe Tratrat (Al-Ahsa, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pyrimido[4,5-b]indole compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrimido[4,5-b]indole compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditi...